Glaukos Corporation
GKOS
Kedudukan dalam Saham
#2087
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Harga Saham
$166.79
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$9.84B
Perubahan (1 hari)
1.44%
Perubahan (1 tahun)
109.88%
Negara
US
Perdagangan Glaukos Corporation (GKOS)
Kategori
Healthcare
Sejarah pecahan saham untuk Glaukos Corporation (GKOS)
Saham Glaukos Corporation (simbol: GKOS) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Oct 20, 2026.
Satu saham GKOS yang dibeli sebelum Oct 20, 2026 kini bersamaan dengan 0 saham GKOS.
Pecahan saham terkini berlaku pada Oct 20, 2026.
Satu saham GKOS yang dibeli sebelum Oct 20, 2026 kini bersamaan dengan 0 saham GKOS.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | |||
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 9 | x285 |
US
|
|
| 7 | x127 |
IE
|
|
| 9 | x162 |
US
|
|
| 2 | x4 |
US
|
|
| 0 | - |
DE
|
